BeOne Medicines (BEIGF) Net Equity Issued and Repurchased (2020 - 2021)
BeOne Medicines' (BEIGF) quarterly Net Equity Issued and Repurchased came in at $50000.0 in Q3 2021, down 100.0% year-over-year from $2.1 billion in Q3 2020, and down 100.0% quarter-over-quarter from $2.1 billion in Q3 2020.
Powered by 
Analysis
BeOne Medicines (BEIGF) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
BeOne Medicines (BEIGF) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $50000.0 the latest figure, recorded in Q3 2021.
- On a quarterly basis, Net Equity Issued and Repurchased fell 100.0% year-over-year to $50000.0 in Q3 2021; TTM through Dec 2022 was $50000.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at $50.0 million, down 98.82% from the prior year.
- Net Equity Issued and Repurchased was $50000.0 for Q3 2021 at BeOne Medicines, down from $2.1 billion in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $2.2 billion in Q1 2020 and troughed at $50000.0 in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | - |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | 141.90 Mn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 50,000.00 |
| Sep 30, 2020 | 2.07 Bn |
| Mar 31, 2020 | 2.16 Bn |